Gene · 3425
Papers1,870
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,870
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| α-L-iduronidase fused with humanized anti-human transferrin receptor antibody (lepunafusp alfa) for mucopolysaccharidosis type I: A phase 1/2 trial. | Mol Ther | 2024 | 38204164 | PubTator, text mining | PubMed |
| Cerebrospinal fluid proteomics in patients with Alzheimer's disease reveals five molecular subtypes with distinct genetic risk profiles. | Nat Aging | 2024 | 38195725 | PubTator, text mining | PubMed |
| omicSynth: An open multi-omic community resource for identifying druggable targets across neurodegenerative diseases. | Am J Hum Genet | 2024 | 38181731 | PubTator, text mining | PubMed |
| Combining angiotensin receptor blockade and enzyme replacement therapy for vascular disease in mucopolysaccharidosis type I. | Mol Genet Metab Rep | 2024 | 38173710 | PubTator, text mining | PubMed |
| Antizyme inhibitor family: biological and translational research implications. | Cell Commun Signal | 2024 | 38169396 | PubTator, text mining | PubMed |
| Co-Analysis of Serum and Urine Differentially Expressed Proteins in Mucopolysaccharidosis Type I. | J Proteome Res | 2024 | 38164767 | PubTator, text mining | PubMed |
| Newborn Screening of 6 Lysosomal Storage Disorders by Tandem Mass Spectrometry. | Clin Pediatr (Phila) | 2024 | 38135922 | PubTator, text mining | PubMed |
| Venetoclax-based low intensity therapy in molecular failure of NPM1-mutated AML. | Blood Adv | 2024 | 38039513 | PubTator, text mining | PubMed |
| Mutations in CFAP47, a previously reported MMAF causative gene, also contribute to the respiratory defects in patients with PCD. | Mol Genet Genomic Med | 2024 | 37723893 | PubTator, text mining | PubMed |
| Intra-Articular AAV9 α-l-Iduronidase Gene Replacement in the Canine Model of Mucopolysaccharidosis Type I. | Adv Cell Gene Ther | 2023 | 40881820 | PubTator, text mining | PubMed |
Evaluation of etanercept (a tumor necrosis factor alpha inhibitor) as an effective treatment for joint disease in mucopolysaccharidosis type I. A case report with whole-body magnetic resonance imaging. | Front Med (Lausanne) | 2023 | 38314027 | PubTator, text mining | PubMed |
| Molecular docking analysis of a dermatan sulfate tetra-saccharide to human alpha-L-iduronidase. | Bioinformation | 2023 | 38250526 | PubTator, text mining | PubMed |
| Altered Sphingolipid Hydrolase Activities and Alpha-Synuclein Level in Late-Onset Schizophrenia. | Metabolites | 2023 | 38248833 | PubTator, text mining | PubMed |
| Light and Shadows in Newborn Screening for Lysosomal Storage Disorders: Eight Years of Experience in Northeast Italy. | Int J Neonatal Screen | 2023 | 38248631 | PubTator, text mining | PubMed |
| Mucopolysaccharidosis Type I: The Importance of Early Diagnosis for Adequate Treatment. | Cureus | 2023 | 38222174 | PubTator, text mining | PubMed |
| Harnessing ADAR-Mediated Site-Specific RNA Editing in Immune-Related Disease: Prediction and Therapeutic Implications. | Int J Mol Sci | 2023 | 38203521 | PubTator, text mining | PubMed |
| Leveraging diverse cell-death related signature predicts the prognosis and immunotherapy response in renal clear cell carcinoma. | Front Immunol | 2023 | 38146369 | PubTator, text mining | PubMed |
| The ethics of sense-making. | Front Psychol | 2023 | 38144992 | PubTator, text mining | PubMed |
| cLD: Rare-variant linkage disequilibrium between genomic regions identifies novel genomic interactions. | PLoS Genet | 2023 | 38109434 | PubTator, text mining | PubMed |
| Computational profiling and prognostic modeling based on lysosome-related genes in colorectal cancer. | Front Genet | 2023 | 38075693 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3425/papers?page=7